Francesco Torino

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Giampietro Gasparini, Massimo Gion, Luigi Mariani et al. · Breast Cancer Research and Treatment · 2006 · 135 citations · Full text

Breast Oncology, Phase Ii Trial, Medicine +8

Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer

Luca Falzone, Saverio Candido, Rossella Salemi et al. · Oncotarget · 2016 · 84 citations · Full text

Engineering, Pathology, Tumor Biology +17

Poly(ADP‐ribose) polymerase inhibitor increases growth inhibition and reduces G₂/M cell accumulation induced by temozolomide in malignant glioma cells

Lucio Tentori, Ilaria Portarena, Francesco Torino et al. · Glia · 2002 · 65 citations

A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer

Giampietro Gasparini, Francesco Torino, Takayuki Ueno et al. · Angiogenesis · 2012 · 49 citations · Full text

Surgical Oncology, Radiation Therapy, Medicine +9

Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer

Alessandro Morabito, Raffaele Longo, Domenico Gattuso et al. · Oncology Reports · 2006 · 34 citations · Full text